Mullah Abdul Ghani Beradar Akhund visits Snow Pharma pharmaceutical factory in Kandahar

fdpm_admin
Mon, May 30 2022 10:36 AM
Snow

May 6, 2022

 

Mullah Abdul Ghani Beradar Akhund, First Deputy Prime Minister, met with a number of investors and traders at Snow Pharma pharmaceutical factory in Kandahar and encouraged them to invest in the country.

The First Deputy Prime Minister said the presence of such a large and standard pharmaceutical factory in Kandahar is a matter of pride for all the people of the country, adding that the Snow Pharma pharmaceutical factory will solve most of the drug related problems in the region and its medicines will reach other parts of the country.

During the meeting, investors and businessmen shared some problems related to trade and investment with Mullah Abdul Ghani Beradar Akhund and asked for cooperation from the Islamic Emirate. The First Deputy Prime Minister assured the investors and traders of the solution to these problems and said that the Islamic Emirate of Afghanistan supports the traders and investors and is ready for any kind of cooperation with them.

Latest news

Wed, Feb 25 2026 9:18 AM
Background image

Regular Meeting of the Economic Commission Held

The regular meeting of the Economic Commission was held today, Tuesday, February 24, 2026, at the Marmarin Palace under the chairmanship of the Deputy PM for Economic Affairs, Mullah. . .

Sun, Feb 22 2026 8:55 AM
Background image

The National Procurement Commission Approved 22 Projects Worth About 10.2 Billion Afghanis

The regular meeting of the National Procurement Commission was held today, Saturday, February 21, 2026, at the Marmarin Palace, under the chairmanship of the Deputy PM for Economic. . .

Wed, Feb 18 2026 11:47 AM
Background image

The proposals for the construction of commercial markets in Sar-e-Pul and Jowzjan provinces were deemed approvable.

The regular meeting of the Inter-Ministerial Investment Committee was held on February 17, 2026 at the Marmarin Palace. During the meeting, the report of the designated committee. . .

BACK TO NEWS